"Chemokine CCL4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC chemokine with specificity for CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES and a variety of other immune cells. This chemokine is encoded by multiple genes.
| Descriptor ID |
D054407
|
| MeSH Number(s) |
D12.644.276.374.200.110.200 D12.644.276.374.200.600.200 D12.776.467.374.200.110.200 D12.776.467.374.200.600.200 D23.125.300.110.200 D23.125.300.600.750 D23.469.200.110.200 D23.529.374.200.110.200 D23.529.374.200.600.200
|
| Concept/Terms |
Chemokine CCL4- Chemokine CCL4
- CCL4, Chemokine
- Macrophage Inflammatory Protein 1-beta
- Macrophage Inflammatory Protein 1 beta
- MIP-1beta
- MIP 1beta
- CCL4 Chemokine
- Chemokine, CCL4
Chemokine CCL4L1- Chemokine CCL4L1
- CCL4L1, Chemokine
- Macrophage Inflammatory Protein-1beta2
- Inflammatory Protein-1beta2, Macrophage
- Macrophage Inflammatory Protein 1beta2
- CCL4L1 Chemokine
- Chemokine, CCL4L1
Chemokine CCL4L2- Chemokine CCL4L2
- CCL4L2, Chemokine
- CCL4L2 Chemokine
- Chemokine, CCL4L2
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL4".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL4".
This graph shows the total number of publications written about "Chemokine CCL4" by people in this website by year, and whether "Chemokine CCL4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL4" by people in Profiles.
-
Snyder-Cappione JE, Tincati C, Eccles-James IG, Cappione AJ, Ndhlovu LC, Koth LL, Nixon DF. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-a and MIP1-?, a lack of IL-17, and a Th1-bias in males. PLoS One. 2010 Nov 03; 5(11):e15412.
-
Maskarinec G, Oum R, Chaptman AK, Ognjanovic S. Inflammatory markers in a randomised soya intervention among men. Br J Nutr. 2009 Jun; 101(12):1740-4.
-
Blum DL, Koyama T, M'Koma AE, Iturregui JM, Martinez-Ferrer M, Uwamariya C, Smith JA, Clark PE, Bhowmick NA. Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin Cancer Res. 2008 Dec 01; 14(23):7790-7.
-
Vil? LM, Molina MJ, Mayor AM, Cruz JJ, R?os-Olivares E, R?os Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol. 2007 May; 26(5):718-22.
-
Miyazaki D, Nakamura T, Toda M, Cheung-Chau KW, Richardson RM, Ono SJ. Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest. 2005 Feb; 115(2):434-42.
-
Cardona AE, Gonzalez PA, Teale JM. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect Immun. 2003 May; 71(5):2634-42.
-
Bosco MC, Rapisarda A, Reffo G, Massazza S, Pastorino S, Varesio L. Macrophage activating properties of the tryptophan catabolite picolinic acid. Adv Exp Med Biol. 2003; 527:55-65.
-
Rapisarda A, Pastorino S, Massazza S, Varesio L, Bosco MC. Antagonistic effect of picolinic acid and interferon-gamma on macrophage inflammatory protein-1alpha/beta production. Cell Immunol. 2002 Nov; 220(1):70-80.
-
Lillard JW, Singh UP, Boyaka PN, Singh S, Taub DD, McGhee JR. MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood. 2003 Feb 01; 101(3):807-14.
-
Takami S, Minami M, Katayama T, Nagata I, Namura S, Satoh M. TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2002 Jul; 22(7):780-4.